| Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis S Sawcer, G Hellenthal, M Pirinen, CCA Spencer, NA Patsopoulos, ... Nature 476 (7359), 214, 2011 | 2356 | 2011 |
| Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. JZ Liu Nature genetics 47 (9), 979-986, 2015 | 1336 | 2015 |
| Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. X Montalban New England Journal of Medicine, 2017 | 990 | 2017 |
| Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis AH Beecham, NA Patsopoulos, DK Xifara, MF Davis, A Kemppinen, ... Nature genetics 45 (11), 1353, 2013 | 936 | 2013 |
| Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity P Browne, D Chandraratna, C Angood, H Tremlett, C Baker, BV Taylor, ... Neurology 83 (11), 1022-1024, 2014 | 879 | 2014 |
| Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci PL De Jager, X Jia, J Wang, PIW De Bakker, L Ottoboni, NT Aggarwal, ... Nature genetics 41 (7), 776, 2009 | 848 | 2009 |
| Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis S Simpson, L Blizzard, P Otahal, I Van der Mei, B Taylor Journal of Neurology, Neurosurgery & Psychiatry 82 (10), 1132-1141, 2011 | 716 | 2011 |
| Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, R Simmons, ... Bmj 327 (7410), 316, 2003 | 654 | 2003 |
| Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis S Simpson Jr, B Taylor, L Blizzard, AL Ponsonby, F Pittas, H Tremlett, ... Annals of neurology 68 (2), 193-203, 2010 | 494 | 2010 |
| Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 Australia and New Zealand Multiple Sclerosis Genetics Consortium Nature genetics 41 (7), 824, 2009 | 445 | 2009 |
| The fine-scale genetic structure of the British population. s Leslie Nature 519 (7543), 2015 | 377 | 2015 |
| Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, BV Taylor, T Kilpatrick, ... Journal of neurology 254 (5), 581-590, 2007 | 370 | 2007 |
| Sun exposure and vitamin D are independent risk factors for CNS demyelination RM Lucas, AL Ponsonby, K Dear, PC Valery, MP Pender, BV Taylor, ... Neurology 76 (6), 540-548, 2011 | 362 | 2011 |
| Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci NA Patsopoulos, ... Annals of neurology 70 (6), 897-912, 2011 | 305 | 2011 |
| Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. F Lublin, D Miller Lancet 387 (10023), 1075-84, 2016 | 296 | 2016 |
| Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype EK Mathey, SB Park, RAC Hughes, JD Pollard, PJ Armati, MH Barnett, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (9), 973-985, 2015 | 273 | 2015 |
| Prevalence and concurrence of anxiety, depression and fatigue over time in multiple sclerosis B Wood, IAF Van Der Mei, AL Ponsonby, F Pittas, S Quinn, T Dwyer, ... Multiple Sclerosis Journal 19 (2), 217-224, 2013 | 255 | 2013 |
| MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood MB Cox, MJ Cairns, KS Gandhi, AP Carroll, S Moscovis, GJ Stewart, ... PloS one 5 (8), e12132, 2010 | 247 | 2010 |
| Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects NA Patsopoulos, LF Barcellos, RQ Hintzen, C Schaefer, CM Van Duijn, ... PLoS Genet 9 (11), e1003926, 2013 | 245 | 2013 |
| Diabetic neuropathies: classification, clinical features, and pathophysiological basis M Sinnreich, BV Taylor, PJB Dyck The neurologist 11 (2), 63-79, 2005 | 239 | 2005 |
Ingrid van der MeiMenzies Institute for Medical Research, University of TasmaniaVerified email at utas.edu.au
